The test kit will measure the amount of beta-amyloid protein in a small amount of blood drawn from a patient and provide early diagnosis and treatment.
Japan’s Ministry of Health, Labor and Welfare has given the go-ahead for a blood test kit that detects symptoms of Alzheimer’s disease.
A diagnostic test produced by Sysmex in Kobe can measure beta-amyloid in the brains of Alzheimer’s patients.
The test kit will measure the amount of beta-amyloid protein in a small amount of blood drawn from a patient and provide early diagnosis and treatment.
The abnormal protein, which damages nerve cells in the brain, is known to be a symptom of Alzheimer’s disease.